respiratory
Infectious diseases

Australian experience of amikacin in NTM disease


Amikacin causes little toxicity in carefully selected and closely monitored patients with non-tuberculous mycobacterial (NTM) disease but is less effective than previously thought, according to a case series published by Brisbane respiratory physicians. Dr Claire Ellender, from the Princess Alexandra Hospital, and colleagues described 45 patients treated at three Brisbane hospitals between 2002 and 2012. ...

Already a member?

Enter your email to keep reading.


OR